COMPANY INFO
   CORPORATE OVERVIEW
   MANAGEMENT TEAM
   INVESTOR RELATIONS
   HISTORY
   CAREERS
   CONTACT US
   AFFILIATE PROGRAM
 

 CAN WE HELP YOU WITH:
   TELEMETRY
   CARDIAC CARE
   OPHTHALMOLOGY
 

Starting from the basement of his home, he founded Heart Guard ultimately becoming one of the leading providers of cardiac monitoring services (TTM) serving over 20 states with revenues of over $5m within 12 months.

Since then, MSO has been involved in the development of product based and service based healthcare ventures, and continuously provides consulting services leveraging its experience with regulatory affairs and technology integration.

Ventures and Startups

• Bergen Medical Imaging, LLC.
  Fixed Site Diagnostic Testing Facility
  Established: 1994
  Formed as a partnership with W.R. Grace, BMI was created as the largest fixed site nuclear diagnostic testing facility of its kind. With 4,000 sq. feet of office space and a multitude of testing modalities, BMI went on to develop and deploy the latest in cardiac diagnostic testing. In 1995 BMI was the first diagnostic testing facility to perform 2 day gated SPECT studies - a modality that has since become the milestone of cardiac nuclear stress testing in the years that followed. The facility ultimately provided services to over 600 physicians in the areas of Nuclear Testing (cardiac, thyroid, bone, renal and more), Ultrasonography, Bone Mineral Testing for Osteoporosis and monitoring services. DMI's interest shares were sold in 2001.
   
• Titanium Ventures Services, Inc. (TVS)
  Venture Capital Investment Firm
  Established: 2002
  TVS identifies promising technologies that have matured and are ready to go to the market. Its mission is to build value for clients through unique full service approach designed for early-stage healthcare emerging companies.

  TVS offers start-up operations a combination of investment banking services and affordable complement of senior level hands-on executive expertise. We are enabling our customers to quickly raise the needed capital while assisting with product introductions, expanding to new geographical markets, and going through organizational changes.

  The TVS team is a well-knit group of senior executives who average 20+ years of domestic and international experience in successfully financing and driving top line growth for start-up companies.

  Unlike traditional consulting organizations or investment banks, TVS executives and associates work as an integral part of our client teams to successfully implement all the necessary actions to grow your business.

  Click here for more information

Marketing Partnerships

• Neurovision, Inc.
  Marketing Agreement
  NeuroVision developed a revolutionary non invasive treatment for Amblyopia that is clinically sound and cleared by the FDA for marketing in the U.S. MSO retains the exclusive rights for marketing in the U.S., and has assisted the manufacturer with regulatory affairs issues, marketing and product development in order to convert a proven technology to a marketable product. MSO developed brochures, leaflets, electronic media and colateral marketing items for conferences and exhibitions (banners, booth design, lighting, etc). MSO successfully secured the support of Dr.  Leonard Press - President of the College of Optometrists in Vision Development, a world renounced authority in ocular health, in the introduction of the product for the American market.

Product Development

• Cardiac Signal Analysis / HeartGuard

Regulatory Affairs

• FDA / Purilens
• FDA / Aerotel
• Medicare / Heart Guard
• MTLF 2003

• TIC/TOC: DMI developed several managed care policy programs collectively known as TIC/TOC: Target Incidence/Target Outcome Capitation. TIC/TOC capitation is a risk-sharing model which allows for rigorous controls over the quality of healthcare delivery. By realigning the incentives of specialists, TIC/TOC transforms the primary physician’s task from gatekeeper to patient advocate. In doing so, TIC/TOC has shown to trigger significant reduction in the perscription of unnecessary procedures. MSO developed and implemented a new approach to control the costs of cardiac clinical care, managing the 3 levels of candidate identification: Clinical analysis, diagnostic testing and the invasive procedure. The concept is based on "Contact Capitation" of a full service, i.e. a fixed price for diagnosing a cardiac patient (regardless of the number of tests required) and a fixed price for interventional treatment, including catheterization and surgery if needed. Target Outcome Capitation (TOC) was introduced in the middle of 1996. The plan provides powerful controls over the quality of procedures performed and provides an incentive for participating physicians to provide the best of service while controlling costs.

• MSO's Physician Network
  MSO acts as an integrator of unique capitation programs with networks of specialists, hospitals and outpatient facilities. Managed care organizations which implement these models can experience significant savings over traditional capitation models and case rates. MSO’s packages require sophisticated information management systems to take full advantage of the inherent benefits.